Neurogene (NGNE) Prepaid Assets (2013 - 2026)
Neurogene (NGNE) posted Prepaid Assets of $181000.0 for Q1 2026, down 93.43% on a QoQ basis from $2.8 million in Q4 2025, and down 95.23% year-over-year from $3.8 million in Q1 2025.
Neurogene (NGNE) Prepaid Assets (2013 - 2026) Analysis & Trends
Neurogene's Prepaid Assets history runs 10 years deep, the most recent figure standing at $181000.0 for Q1 2026.
- Quarterly Prepaid Assets fell 95.23% year-over-year to $181000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $181000.0 (down 95.23% YoY) and the FY2025 annual result came in at $2.8 million, up 181.04% from the prior year.
- Prepaid Assets was $181000.0 for Q1 2026 at Neurogene, down from $2.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $4.7 million in Q3 2024 and bottomed at $181000.0 in Q1 2026.
- A 5-year average of $2.0 million and a median of $2.0 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets surged 235.79% — and 2025, when it tumbled 95.53%.
- Neurogene's Prepaid Assets stood at $2.7 million in 2022, then climbed by 18.27% to $3.2 million in 2023, then tumbled by 69.26% to $981000.0 in 2024, then soared by 181.04% to $2.8 million in 2025, then slumped by 93.43% to $181000.0 in 2026.
- Business Quant data shows NGNE's Prepaid Assets at $181000.0 in Q1 2026, $2.8 million in Q4 2025, and $208000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181,000.00 |
| Dec 31, 2025 | 2.76 Mn |
| Sep 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 970,000.00 |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 981,000.00 |
| Sep 30, 2024 | 4.65 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 1.39 Mn |
| Jun 30, 2023 | 1.72 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 2.70 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 2.03 Mn |
| Mar 31, 2022 | 2.31 Mn |
| Dec 31, 2021 | 1.52 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 3.26 Mn |